Show simple item record

Update on the electrolytic IVC model for pre‐clinical studies of venous thrombosis

dc.contributor.authorPalmer, Olivia R.
dc.contributor.authorShaydakov, Maxim E.
dc.contributor.authorRainey, Joshua P.
dc.contributor.authorLawrence, Daniel A.
dc.contributor.authorGreve, Joan M.
dc.contributor.authorDiaz, José A.
dc.date.accessioned2018-05-15T20:16:21Z
dc.date.available2019-06-03T15:24:19Zen
dc.date.issued2018-04
dc.identifier.citationPalmer, Olivia R.; Shaydakov, Maxim E.; Rainey, Joshua P.; Lawrence, Daniel A.; Greve, Joan M.; Diaz, José A. (2018). "Update on the electrolytic IVC model for pre‐clinical studies of venous thrombosis." Research and Practice in Thrombosis and Haemostasis 2(2): 266-273.
dc.identifier.issn2475-0379
dc.identifier.issn2475-0379
dc.identifier.urihttps://hdl.handle.net/2027.42/143801
dc.description.abstractEssentialsThree key updates are provided on the electrolytic inferior vena cava model (EIM).The originally described stimulator equipment has been discontinued; we developed an alternative.The fibrinolytic system and the current and time dependency of the EIM was characterized.EIM allows the investigation of the fibrinolytic system, critical for endovascular therapies.BackgroundThe electrolytic inferior vena cava model (EIM) is a murine venous thrombosis (VT) model that produces a non‐occlusive thrombus. The thrombus forms in the direction of blood flow, as observed in patients. The EIM is valuable for investigations of therapeutics due to the presence of continuous blood flow. However, the equipment used to induce thrombosis in the original model description was expensive and has since been discontinued. Further, the fibrinolytic system had not been previously studied in the EIM.ObjectivesWe aimed to provide an equipment alternative. Additionally, we further characterized the model through mapping the current and time dependency of thrombus resolution dynamics, and investigated the fibrinolytic system from acute to chronic VT.ResultsA voltage to current converter powered by a direct current power supply was constructed and validated, providing an added benefit of significantly reducing costs. The current and time dependency of thrombus volume dynamics was assessed by MRI, demonstrating the flexibility of the EIM to investigate both pro‐thrombotic and anti‐thrombotic conditions. Additionally, the fibrinolytic system was characterized in EIM. Centripetal distribution of plasminogen was observed over time, with peak staining at day 6 post thrombus induction. Both active circulating plasminogen activator inhibitor‐1 (PAI‐1) and vein wall gene expression of PAI‐1 peaked at day 2, coinciding with a relative decrease in tissue plasminogen activator and urokinase plasminogen activator.ConclusionsThe EIM is a valuable model of VT that can now be performed at low cost and may be beneficial in investigations of the fibrinolytic system.
dc.publisherWiley Periodicals, Inc.
dc.publisherNational Academies Press (US)
dc.subject.otheranimal models
dc.subject.otherveins
dc.subject.othermagnetic resonance imaging
dc.subject.otherfibrinolysis
dc.subject.otherelectrolysis
dc.subject.othereim
dc.subject.othervenous thrombosis
dc.subject.othervenous thromboembolism
dc.titleUpdate on the electrolytic IVC model for pre‐clinical studies of venous thrombosis
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHematology and Oncology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/143801/1/rth212074.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/143801/2/rth212074_am.pdf
dc.identifier.doi10.1002/rth2.12074
dc.identifier.sourceResearch and Practice in Thrombosis and Haemostasis
dc.identifier.citedreferenceDiaz JA, Wrobleski SK, Hawley AE, Lucchesi BR, Wakefield TW, Myers DD. Electrolytic inferior vena cava model (EIM) of venous thrombosis. J Vis Exp. 2011; 53: e2737.
dc.identifier.citedreferenceDiaz JA, Alvarado CM, Wrobleski SK, et al. The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse. Thromb Haemost. 2013; 109: 1158 – 69.
dc.identifier.citedreferenceWojcik BM, Wrobleski SK, Hawley AE, Wakefield TW, Myers DD, Diaz JA. Interleukin‐6: a potential target for post‐thrombotic syndrome. Ann Vasc Surg. 2011; 25: 229 – 39.
dc.identifier.citedreferenceGarber JC, Barbee RW, Bielitzki JT, et al. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: National Academies Press (US); 2011.
dc.identifier.citedreferenceLin M, Hsieh JCF, Hanif M, McDaniel A, Chew DK. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral‐popliteal venous segment involvement. J Vasc Surg Venous Lymphat Disord. 2017; 5: 613 – 20.
dc.identifier.citedreferenceSugimoto K, Hofmann LV, Razavi MK, et al. The safety, efficacy, and pharmacoeconomics of low‐dose alteplase compared with urokinase for catheter‐directed thrombolysis of arterial and venous occlusions. J Vasc Surg. 2003; 37: 512 – 7.
dc.identifier.citedreferenceBanno F, Kita T, Fernández JA, et al. Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation. Blood. 2015; 126: 2247 – 53.
dc.identifier.citedreferenceDiaz JA. Animal models of VT: to change or not to change? Blood. 2015; 126: 2177 – 8.
dc.identifier.citedreferenceDiaz JA, Hawley AE, Alvarado CM, et al. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost. 2010; 104: 366 – 75.
dc.identifier.citedreferenceMeissner MH, Zierler BK, Bergelin RO, Chandler WL, Strandness DE. Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis. J Vasc Surg. 2002; 35: 278 – 85.
dc.identifier.citedreferenceVedantham S. Catheter‐directed thrombolysis to avoid late consequences of acute deep vein thrombosis. Thromb Res. 2017; 164: 125 – 8.
dc.identifier.citedreferenceVedantham S, Goldhaber SZ, Kahn SR, et al. Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter‐directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. Am Heart J. 2013; 165: e3.
dc.identifier.citedreferenceRomson JL, Haack DW, Lucchesi BR. Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti‐thrombotic agents. Thromb Res. 1980; 17: 841 – 53.
dc.identifier.citedreferenceDiaz JA, Ballard‐Lipka NE, Farris DM, et al. Impaired fibrinolytic system in ApoE gene‐deleted mice with hyperlipidemia augments deep vein thrombosis. J Vasc Surg. 2012; 55: 815 – 22.
dc.identifier.citedreferenceLynch S, Figueroa CA, Diaz J, et al. Semiautomatic computational method for the quantification of histologic elements of experimental venous thrombi. J Vasc Surg Venous Lymphat Disord. 2017; 5: 146 – 7.
dc.identifier.citedreferencePatterson KA, Zhang X, Wrobleski SK, et al. Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non‐lipid lowering effects. Thromb Res. 2013; 131: 268 – 76.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.